ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0841

Relation of PainDETECT to Unpredictable Pain in People with or at Risk of Knee Osteoarthritis

Kosaku Aoyagi1, Laura Frey-Law2, Gabriela Rabasa3, Cora E. Lewis4, Michael Nevitt5 and Tuhina Neogi6, 1Boston University, Quincy, MA, 2University of Iowa, Iowa City, IA, 3Boston University, Boston, MA, 4University of Alabama at Birmingham, Birmingham, AL, 5University of California at San Francisco, Orinda, CA, 6Boston University School of Medicine, Boston, MA

Meeting: ACR Convergence 2022

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Orthopedics, Low Back Pain, and Rehabilitation Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: PainDETECT has been used in studies of knee OA to identify “neuropathic-like pain”, though neuropathic lesions have not been identified in clinical knee OA. PainDETECT, however, is also associated with measures of pain sensitization. Unpredictable knee pain is another type of pain experienced in knee OA that is emotionally draining and has negative impacts on quality of life. Unpredictable pain has been poorly correlated with other pain experiences in knee OA, such as intermittent or constant pain, or pain severity. This suggests that unpredictable pain may reflect a different construct. Whether PainDETECT and unpredictable pain reflect similar underlying mechanisms of altered nociceptive functioning is not known. Therefore, we sought to determine the association between PainDETECT and unpredictable pain in people with knee OA.

Methods: We included participants from the Multicenter Osteoarthritis (MOST) Study, a NIH-funded longitudinal cohort study of persons with or at risk of knee OA. PainDETECT was dichotomized at >12 to reflect possible or probable neuropathic-like pain in knee OA. We evaluated unpredictable pain using a single standalone question from the Intermittent and Constant Osteoarthritis Pain (ICOAP) questionnaire: “How often does your knee pain that comes and goes come on without warning?” with five levels of response from never (0) to very often (4). We defined presence of unpredictable pain as occurring at least “often”. We evaluated the cross-sectional relation of having a PainDETECT score >12 to presence of unpredictable pain using knee-based logistic regression with the generalized estimating equation to account for correlations between the knees within an individual, adjusting for age, sex, BMI, race, catastrophizing, and depressive symptoms.

Results: We included 1998 participants (3984 knees) (mean age 66.8 ± 11.2, 58.1% female, mean BMI 29.5 ± 5.7). Of those, 10.6% had a PainDETECT score >12 and 9.3% had unpredictable pain (present “at least often”). Participants with a PainDETECT score >12 had 3-fold greater likelihood of having unpredictable pain compared with those whose score was ≤12 (adjusted odds ratio: 3.14, 95% CI 2.19, 4.49).

Conclusion: PainDETECT scores above the threshold typically used to define possible or probable ‘neuropathic-like pain’ was associated with unpredictable pain, suggesting a common underlying involvement of the altered nociceptive pathways contributing to distressing pain symptoms in people with knee OA. This study highlights the importance of targeting altered functioning of nociceptive pathways to address unpredictable pain and improve the quality of life in people with knee OA.


Disclosures: K. Aoyagi, None; L. Frey-Law, None; G. Rabasa, None; C. Lewis, None; M. Nevitt, None; T. Neogi, Novartis, Pfizer/Lilly, Regeneron.

To cite this abstract in AMA style:

Aoyagi K, Frey-Law L, Rabasa G, Lewis C, Nevitt M, Neogi T. Relation of PainDETECT to Unpredictable Pain in People with or at Risk of Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/relation-of-paindetect-to-unpredictable-pain-in-people-with-or-at-risk-of-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relation-of-paindetect-to-unpredictable-pain-in-people-with-or-at-risk-of-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology